FDA Pregnancy CategoriesThe Food and Drug Administration has established five categories to indicate the potential for a systemically absorbed drug to cause birth defects. The key differentiation among the categories rests upon the degree (reliability) of documentation and the risk-benefit ratio.
Category A:
Adequate studies in pregnant women have not demonstrated a risk to the fetus in the first trimester of pregnancy, and there is no evidence of risk in later trimesters.
Related posts:
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
